Clinical Validation of KIT Inhibition in Advanced Systemic Mastocytosis

被引:0
作者
John H. Baird
Jason Gotlib
机构
[1] Stanford Cancer Institute / Stanford University School of Medicine,Division of Hematology
来源
Current Hematologic Malignancy Reports | 2018年 / 13卷
关键词
Systemic mastocytosis; KIT D816V; Midostaurin; Avapritinib; Imatinib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:407 / 416
页数:9
相关论文
共 640 条
[61]  
Pedreira Carlos E(2014)CD52 is a molecular target in advanced systemic mastocytosis The FASEB Journal 28 3540-undefined
[62]  
Matito Almudena(2016)Consensus opinion on allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis Biol Blood Marrow Transplant 22 1348-undefined
[63]  
Morgado Jose Mario T(2014)Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis Journal of Clinical Oncology 32 3264-undefined
[64]  
Sánchez Maria Luz(2007)Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches Science 318 1296-undefined
[65]  
Mollejo Manuela(2016)Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy Sci Transl Med 8 351ra105-undefined
[66]  
Gonzalez-de-Olano David(2016)Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis Allergy 71 1585-undefined
[67]  
Orfao Alberto(undefined)undefined undefined undefined undefined-undefined
[68]  
Escribano Luis(undefined)undefined undefined undefined undefined-undefined
[69]  
Lanternier Fanny(undefined)undefined undefined undefined undefined-undefined
[70]  
Cohen-Akenine Annick(undefined)undefined undefined undefined undefined-undefined